Joint Polish Investment Fund Management B.V. is a venture capital firm established in 2015 and headquartered in Warsaw, Poland, with an additional office in Broek in Waterland, Netherlands. The firm specializes in early to growth stage investments in life science companies, focusing on areas such as medical technology, mobile and personalized health, diagnostics, and drug development. Its medical technology investments emphasize innovative materials, microelectronics, IT applications in medical devices, and minimally invasive procedures. In diagnostics, the firm targets monitoring chronic diseases and personalized medicine, particularly in relation to recent advances in immuno-oncology. Joint Polish Investment Fund seeks to create a high return investment portfolio by investing primarily in Central and Eastern European companies, especially those based in Poland, and typically invests between $0.26 million and $4 million per company. The firm is staffed by a team with extensive experience in both the life sciences and business sectors, enabling it to provide valuable support to entrepreneurs throughout the development process.
DreamJay Inc., founded in 2015 and based in Berkeley, California, specializes in developing mobile medical applications aimed at improving sleep quality. Its flagship product, the Nightly app, is designed to prevent bad dreams and assist individuals with sleep disorders in managing their sleep without the need for pharmaceuticals. Through extensive research and collaboration with experts in sleep medicine and neuropsychology, DreamJay has created a solution that utilizes active sleep stimulation to enhance the sleep experience. The Nightly app facilitates easier falling asleep, reduces nighttime awakenings, and limits the occurrence of bad dreams, ultimately promoting a healthier and more efficient sleep cycle. Additionally, it helps users wake up during the lightest sleep stage, contributing to a more refreshed start to the day.
Nightly
Series A in 2017
Nightly helps you enjoy healthy sleep. It actively works to keep your night restful in three ways: it helps you easily fall asleep, limit bad dreams and reduce the likelihood of nighttime awakenings. This innovative, scientifically-developed technology is a combination of two factors: audio-visual stimuli and advanced AI algorithms. Nightly monitors your sleep live, recognizes critical moments during your night and reacts with soothing sounds to help you minimize the possibility of a wakeup. It stimulates your sleep to help you keep your rest uninterrupted.
Smartmedics
Venture Round in 2017
Smartmedics is a digital healthcare company based in Warsaw, Poland, specializing in advanced electrocardiogram systems. The company combines expertise in research and development, design, engineering, data science, and clinical practice to create innovative healthcare solutions. Smartmedics has developed a device that monitors biosignal parameters through smartphones, utilizing wireless, radiolucent algorithms to analyze the data. This technology enables users to detect cardiac abnormalities, facilitating home monitoring and cardiac telerehabilitation. Through its focus on making biosignals transparent, Smartmedics aims to enhance patient care and improve health outcomes.
Fixnip
Venture Round in 2017
Fixnip Ltd specializes in the development of hypodermic silicone nipple implants aimed at breast reconstruction and the repair of inverted nipples. Founded in 2015 and based in Even Yehuda, Israel, the company’s innovative implants feature a nitinol skeleton that provides mechanical strength while being covered in soft medical silicone. This design ensures that the implants are soft, flexible, and resemble the natural look and feel of breast tissue. The implants are specifically designed for women undergoing post-mastectomy reconstruction, allowing healthcare professionals to securely anchor the implant to adjacent tissue, thereby offering a stable and aesthetically pleasing solution for nipple reconstruction.
PHase2 Micro Technologies
Venture Round in 2016
PHase2 Micro Technologies is a technology development company that offers MEMS-enabled pH sensor technology platforms. PHase2 Micro Technologies’ AccuMET™ pH sensing platforms include single measurement chips (SMCs) designed for discrete single measurements as well as multiple measurement chips (MMCs). They also include continuous self-calibrating chips (CSCs), which are designed to use in continuous monitoring applications. PHase2 Micro Technologies is based in Boston, Massachusetts.
ScaleThings
Venture Round in 2016
ScaleThings is a privately-owned company that specializes in the development and manufacture of tactile-sensing weighing technologies. These proprietary technologies are integrated into a variety of consumer retail products, including those for home use, wearables, health, and baby care. One of its notable innovations is a dual-function bathroom rug that features a built-in body fat analyzer, designed for convenient placement in front of a bathroom sink. This device allows users to easily measure their weight and body composition, providing a hassle-free solution for health monitoring.
AioCare
Seed Round in 2016
AioCare is a medical device company focused on managing pulmonary conditions. Its primary product, MySpiroo, is an ultraportable spirometer designed to aid individuals in controlling asthma and reducing exacerbations, ultimately protecting users from severe attacks. The device connects to a mobile application that records measurement history and employs an advanced algorithm for precise analysis of respiratory parameters. This integration allows users to effectively monitor their respiratory health and maintain a comprehensive log of their data on a compatible smartphone.
Manta Instruments
Series A in 2015
Manta Instruments, Inc., based in La Jolla, California, specializes in developing advanced scientific instruments for the characterization of nanoparticles. Their innovative technology addresses significant limitations of existing products by effectively measuring nanoparticle concentration, analyzing samples with mixed sizes, and reliably tracking changes in size over time. The company's instruments utilize scattered light detection from nanoparticles suspended in liquid, allowing for simultaneous analysis of individual particles. This capability enables clients in biotech, pharmaceuticals, and energy sectors to visualize, count, and accurately measure size, concentration, and distribution of nanoparticles, including proteins, exosomes, and live viruses. Manta Instruments operates as a subsidiary of HORIBA Instruments Inc.
Sound Object Technologies
Seed Round in 2015
Sound Object Technologies specializes in developing innovative technology for processing and analyzing sound signals, with a focus on applications in medical devices. The company’s solutions enable the digitization and vectorization of sound, facilitating advanced capabilities in text-to-speech and speech-to-text functionalities. By providing effective data compression tools, Sound Object Technologies allows users to achieve high-quality signal representation and description, making it possible to isolate individual sound components from complex audio tracks. This technology serves a critical role in enhancing the accuracy and efficiency of audio processing in various fields.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.